Pancreatic Insufficiency Clinical Trials

28 clinical trials for Pancreatic Insufficiency across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance — RECRUITING · PHASE2
• Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis — RECRUITING · PHASE1
• Beta-cell Response to Incretin Hormones in Cystic Fibrosis — RECRUITING · NA
• Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy — COMPLETED · PHASE4
• Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy — NOT_YET_RECRUITING
• Diagnosis and Treatment of Patients With Cystic Fibrosis — TERMINATED
• Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis — COMPLETED
• MRI to Characterize and Predict CF Liver Disease in PUSH Cohort — COMPLETED
• Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation — COMPLETED
• PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial — ACTIVE_NOT_RECRUITING · NA
• Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) — COMPLETED · PHASE2
• Hypoglycemia and Glucagon Response in CF — COMPLETED
• Effect of Chronic Incretin-based Therapy in Cystic Fibrosis — COMPLETED · NA
• Equivalence Study to Compare Two Strengths of Creon in China — OTHER · PHASE3
• PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer — TERMINATED · PHASE1
• Pancreatic Exocrine Insufficiency After Bariatric Surgery — OTHER
• Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis — COMPLETED · NA
• Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) — COMPLETED · PHASE3
• Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) — COMPLETED · PHASE3
• Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis — COMPLETED · PHASE1
• Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency — COMPLETED · PHASE2
• Pancreatic Insufficiency Secondary to Tobacco Exposure — COMPLETED
• Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI — COMPLETED · PHASE2
• Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis — COMPLETED · PHASE3
• Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis — COMPLETED · PHASE3
• Creon After Pancreatic Surgery — COMPLETED · PHASE4
• Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency — OTHER · PHASE2
• Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea — COMPLETED · PHASE4

Refine this search